Cargando…
Motolimod, a selective TLR8 agonist induces apoptosis in monocytic myeloid-derived suppressor cells (M-MDSC)
Autores principales: | Rutnam, Zina J, Dang, Yushe, Dietsch, Gregory, Lu, Hailing, Yang, Yi, Hershberg, Robert M, Disis, Mary |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4649376/ http://dx.doi.org/10.1186/2051-1426-3-S2-P296 |
Ejemplares similares
-
Comparison of immune modulation by TLR8 agonist vtx-2337 (motolimod) in cancer patients and healthy volunteers
por: Dietsch, Greg, et al.
Publicado: (2014) -
Motolimod effectively drives immune activation in advanced cancer patients
por: Dietsch, Gregory N.
Publicado: (2016) -
TLR8 agonist VTX-2337 enhances NKG2D-mediated cytotoxicity of NK cells
por: Lu, Hailing, et al.
Publicado: (2013) -
Coordinated Activation of Toll-Like Receptor8 (TLR8) and NLRP3 by the TLR8 Agonist, VTX-2337, Ignites Tumoricidal Natural Killer Cell Activity
por: Dietsch, Gregory N., et al.
Publicado: (2016) -
Intravenous Immunoglobulins Promote an Expansion of Monocytic Myeloid-Derived Suppressor Cells (MDSC) in CVID Patients
por: Simón-Fuentes, Miriam, et al.
Publicado: (2022)